Outgoing Bristol CEO Giovanni Caforio sat for an exit interview with @matthewher...
Liquid biopsy for cancer recurrence creates a new kind of patient-in-waiting.
The Senate Finance Committee plans to move ahead with a wide-ranging health care...
The Biden administration is slowly shifting millions of Covid-19 treatments to p...
LEO-152020 is under clinical development by Leo Pharma and currently in Phase II...
Osemitamab is under clinical development by Transcenta and currently in Phase II...
BGB-10188 is under clinical development by BeiGene and currently in Phase II for...
BGB-10188 is under clinical development by BeiGene and currently in Phase II for...
BGB-10188 is under clinical development by BeiGene and currently in Phase II for...
Rhenium (186Re) obisbemeda is under clinical development by Plus Therapeutics an...
Rhenium (186Re) obisbemeda is under clinical development by Plus Therapeutics an...
PBCAR-19B is under clinical development by Precision Biosciences and currently i...
DF-003 is under clinical development by Drug Farm and currently in Phase I for C...
(CST-2032 + nadolol) is under clinical development by CuraSen Therapeutics and c...
Read an Ask Me Anything with STAT’s Nicholas St. Fleur: his favorite parts of th...
The proposal aims to increase early communication between insurers and providers...
